FLLHF yields 363.64% · PFE yields 6.13%● Live data
📍 FLLHF pulled ahead of the other in Year 1
Combined, FLLHF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FLLHF + PFE for your $10,000?
Fullshare Holdings Limited, an investment holding company, engages in the property development, sale of gear products, and property investment activities in the People's Republic of China, the United States, Europe, Australia, and internationally. It operates through five segments: Properties; Tourism; Investment and Financial Services; Healthcare, Education, and Others; and New Energy. The company develops and sells properties, including residential, commercial, hotels, offices, apartments, and shopping malls; and provides construction related services. It also holds and invests in various investments and financial products, such as listed and unlisted securities, bonds, funds, derivatives, structured, and other treasury products; offers investment and financial related consulting services; and operates hotels, as well as sells tourist goods and provides related services. In addition, the company engages in the manufacture, distribution, and sale of mechanical transmission equipment; and manufacture and sale of gear products. Further, it provides healthcare and education products and related services; and green building services comprising technical design and consulting, green management, and construction services. The company was formerly known as Warderly International Holdings Limited and changed its name to Fullshare Holdings Limited in October 2014. The company was founded in 2002 and is headquartered in Admiralty, Hong Kong.
Full FLLHF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.